A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/00 (2006.01) A61K 9/127 (2006.01) A61K 31/35 (2006.01) A61K 47/20 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2706923
Compositions and methods for the treatment of bladder cancer include intravesical dosage forms of a neoplastic agent and a permeation enhancer. The neoplastic agent may be valrubicin. Pharmaceutical compositions include intravesical dosage forms of a neoplastic agent complexed liposomes. Tight junction openers may be used for the effective delivery of the neoplastic agent.
L'invention porte sur des compositions et procédés destinés au traitement du cancer de la vessie et incluant des formes posologiques intravésicales d'agent antinéoplasique et un stimulateur de pénétration. L'agent antinéoplasique peut être de la valrubicine. Les compositions pharmaceutiques incluent des formes posologiques intravésicales de liposomes incorporant un complexe d'agent antinéoplasique. Des agents d'ouverture de jonctions serrées peuvent être utilisés pour une administration efficace de l'agent antinéoplasique.
Chaber John
Kuzma Petr
Kydonieus Agis
Endo Pharmaceuticals Solutions Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Compositions and methods for the treatment of bladder cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment of bladder cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment of bladder cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1988220